Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Not applicableUnknownNCT05421572
What this trial is testing

Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Who this might be right for
Fatty Liver Disease
Beijing Tsinghua Chang Gung Hospital 2,000
Not applicableNot Yet RecruitingNCT07085962
What this trial is testing

Efficacy and Safety of Calculus Bovis Sativus in Adults With MAFLD

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease
Huazhong University of Science and Technology 40
Not applicableNot Yet RecruitingNCT06773221
What this trial is testing

The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver DiseaseCompensated Liver Cirrhosis
Beijing Friendship Hospital 195
Not applicableUnknownNCT05880316
What this trial is testing

Prevalence of MAFLD Among Nurses and the Role of Intermittent Fasting

Who this might be right for
Fatty Liver Disease
Universiti Kebangsaan Malaysia Medical Centre 100
Not applicableLooking for participantsNCT06503068
What this trial is testing

Impact of NAFLD vs MAFLD Stigma on Quality of Life in Egyptian Patients

Who this might be right for
NAFLD
Tanta University 500
Not applicableStudy completedNCT05778266
What this trial is testing

Effect of L-citrulline and HIIT on Arterial Stiffness, Body Composition, and Lipid Profile in Adolescents with Steatosis Associated with Metabolic Dysfunction (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Fatty Liver DiseaseObesity, AdolescentArterial Stiffness
Universidad de Guanajuato 43
Not applicableStudy completedNCT07297225
What this trial is testing

Metabolic Dysfunction-Associated Fatty Liver Disease Impairs Intraoperative Indocyanine Green Fluorescence Cholangiography Quality: Development and Validation of a Predictive Model

Who this might be right for
MAFLDCholecystitisGallbladder Polyps+1 more
Zhujiang Hospital 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT07024212
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects

Who this might be right for
MASLD
Zhejiang Doer Biologics Co., Ltd. 110
Large-scale testing (Phase 3)Looking for participantsNCT07165028
What this trial is testing

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company 4,500
Not applicableNot Yet RecruitingNCT07373769
What this trial is testing

Ultrasound Liver Imaging for Classification of Metabolic Dysfunction-associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
University of British Columbia 145
Post-approval studies (Phase 4)Not Yet RecruitingNCT07289750
What this trial is testing

The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLD.

Who this might be right for
T2DMMAFLD
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 80
Not applicableNot Yet RecruitingNCT07391267
What this trial is testing

Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.

Who this might be right for
Chronic Kidney DiseasesMAFLD
Institute of Liver and Biliary Sciences, India 90
Not applicableLooking for participantsNCT06585982
What this trial is testing

Synbiotics Impact on Insulin and TNF-α in MAFLD: a Gut Microbiota Profile Analysis

Who this might be right for
Fatty Liver Disease
Universitas Diponegoro 50
Not applicableNot Yet RecruitingNCT06795646
What this trial is testing

Clinical Classification of MAFLD Based Liver Biopsy

Who this might be right for
Metabolic Dysfunction Associated Steatotic Liver DiseaseMetabolic Dysfunction-associated Steatohepatitis (MASH)
Beijing Friendship Hospital 2,000
Not applicableNot Yet RecruitingNCT07336563
What this trial is testing

ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH)Metabolic SyndromeObesity & Overweight+2 more
Jarosław Drobnik 10,000
Not applicableUnknownNCT05708560
What this trial is testing

Relationship Between MAFLD and Liver Fibrosis Progression in Patients With Chronic Hepatitis B: a Multicenter Retrospective Cohort Study

Who this might be right for
Hepatitis B, Chronic
Erasmus Medical Center 800
Not applicableNot Yet RecruitingNCT06344364
What this trial is testing

Digital Pathology and AI for Liver Outcomes in MASLD

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
PharmaNest, Inc 1,800
Not applicableEnrolling By InvitationNCT06953830
What this trial is testing

Optimal Measurement of Spleen Stiffness Among Veterans With Metabolic Dysfunction-Associated Steatotic Liver Disease

Who this might be right for
Metabolic-dysfunction-associated Fatty Liver Disease (MAFLD)
William Jennings Bryan Dorn VA Medical Center 100
Not applicableLooking for participantsNCT05974904
What this trial is testing

Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver DiseaseHepatic SteatosisLiver Fibrosis
Chongqing Medical University 7,000
Not applicableLooking for participantsNCT07068191
What this trial is testing

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)HepatomegalyNonalcoholic Fatty Liver (NAFL)+5 more
Phenomen Pharma 90
Load More Results